Here’s an ETF to Invest in Immunotherapy--the Game Changing Cancer Treatment

Mar 16, 2018

CNCR ETF is up about 30% this year; here is what investors need to know about immunotherapy and the ETF (CNCR, IBB)

(1:10) - What Is Immunotherapy?

(4:25) - 5 Types Of FDA Approved Immunotherapy

((7:50) - What Kind Of Cancer Does This Treat?

(9:45) - Loncar Cancer Immunotherapy ETF: CNCR

(17:00) - Cancer Research Institute Partnership

(20:45) - What Is Driving The Positive Performance?

(25:00) - Launch Of China Biotech Index

(27:10) - Episode Roundup: [e-mail]